Is solifenacin succinate safe and effective for the treatment of overactive bladder?

Affiliations

Comment

Karyn S Eilber. Nat Clin Pract Urol. 2008 Mar.

. 2008 Mar;5(3):128-9.

doi: 10.1038/ncpuro1040. Epub 2008 Jan 15.

¹ Division of Urology, Harbor-University of California, Los Angeles Medical Center, Los Angeles, CA, USA. karyn.eilber@cshs.org

No abstract available

Comment on

Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder.
Yamaguchi O, Marui E, Kakizaki H, Itoh N, Yokota T, Okada H, Ishizuka O, Ozono S, Gotoh M, Sugiyama T, Seki N, Yoshida M; Japanese Solifenacin Study Group. Yamaguchi O, et al. BJU Int. 2007 Sep;100(3):579-87. doi: 10.1111/j.1464-410X.2007.07031.x. BJU Int. 2007. PMID: 17669143 Clinical Trial.